These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8158579)

  • 1. Labelling of D2-dopaminergic and 5-HT2-serotonergic binding sites in human trophoblastic cells using [3H]-spiperone.
    Vaillancourt C; Petit A; Gallo-Payet N; Bellabarba D; Lehoux JG; Bélisle S
    J Recept Res; 1994 Jan; 14(1):11-22. PubMed ID: 8158579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two classes of [3H]spiperone binding sites in bovine neurohypophysis: D-2 receptors and putative 5-HT2 receptors.
    Treiman M; Andersen PH
    J Recept Res; 1989; 9(4-5):297-312. PubMed ID: 2574236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390.
    Lidow MS; Goldman-Rakic PS; Gallager DW; Rakic P
    Neuroscience; 1991; 40(3):657-71. PubMed ID: 2062437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D2 receptor binding in adrenal medulla: characterization using [3H]spiperone.
    Quik M; Bergeron L; Mount H; Philie J
    Biochem Pharmacol; 1987 Nov; 36(21):3707-13. PubMed ID: 2960326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the presence of D2 and 5-HT2 receptors in the human prefrontal cortex.
    Mita T; Kuno T; Nakai H; Tanaka C
    Jpn J Pharmacol; 1982 Dec; 32(6):1027-32. PubMed ID: 7161958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum.
    Hall H; Wedel I
    Acta Pharmacol Toxicol (Copenh); 1986 May; 58(5):368-73. PubMed ID: 2943136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postnatal development of dopamine D1-like and D2-like receptors in the rat kidney: a radioligand binding study.
    Tenore G; Barili P; Sabbatini M; Tayebati SK; Amenta F
    Mech Ageing Dev; 1997 Apr; 95(1-2):1-11. PubMed ID: 9152957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of D2-dopamine receptors in human term placenta.
    Petit A; Vaillancourt C; Bellabarba D; Lehoux JG; Gallo-Payet N; Bélisle S
    J Recept Res; 1990; 10(3-4):205-15. PubMed ID: 2148190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D2-dopamine agonists inhibit adenosine 3':5'-cyclic monophosphate (cAMP) production in human term trophoblastic cells.
    Vaillancourt C; Petit A; Bélisle S
    Life Sci; 1994; 55(20):1545-52. PubMed ID: 7968225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of dopamine receptors in insect (Apis mellifera) brain.
    Kokay IC; Mercer AR
    Brain Res; 1996 Jan; 706(1):47-56. PubMed ID: 8720491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo binding of (E)- and (Z)-N-(iodoallyl)spiperone to dopamine D2 and serotonin 5-HT2 neuroreceptors.
    Lever JR; Scheffel UA; Stathis M; Musachio JL; Wagner HN
    Life Sci; 1990; 46(26):1967-76. PubMed ID: 2362552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute effect of sertindole on brain 5-HT2, D2 and alpha 1 receptors (ex vivo radioreceptor binding studies).
    Hyttel J; Nielsen JB; Nowak G
    J Neural Transm Gen Sect; 1992; 89(1-2):61-9. PubMed ID: 1329856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA; Szczepanik AM
    Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of the interaction of [3H]spiroperidol with serotonin and dopamine receptors.
    McGonigle P
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S73-7. PubMed ID: 2459520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]nemonapride and [3H]spiperone label equivalent numbers of D2 and D3 dopamine receptors in a range of tissues and under different conditions.
    Vile JM; D'Souza UM; Strange PG
    J Neurochem; 1995 Feb; 64(2):940-3. PubMed ID: 7830089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the kinetics of the interaction of spiperone with binding sites on human mononuclear cells: existence of a heterogeneous population of spiperone binding sites.
    Zaitsev SV; Koshkin AA; Izumrudova II; Varfolomeev SD
    J Neuroimmunol; 1992 Feb; 36(2-3):225-9. PubMed ID: 1732283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex.
    Goldman-Rakic PS; Lidow MS; Gallager DW
    J Neurosci; 1990 Jul; 10(7):2125-38. PubMed ID: 2165520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3H-spiperone labels sigma receptors, not dopamine D2 receptors, in rat and human lymphocytes.
    Coccini T; Manzo L; Costa LG
    Immunopharmacology; 1991; 22(2):93-105. PubMed ID: 1662188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ; Seeman P
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain.
    Peroutka SJ; Snyder SH
    Brain Res; 1981 Mar; 208(2):339-47. PubMed ID: 7214150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.